MORGAN STANLEY PLC/CALL/MERCK & CO./130/0.1/20.12.24 Share Price

Warrant

DE000MB16ZV7

Real-time Bid/Ask 05:00:00 05/07/2024 pm IST
0.57 EUR / 0.59 EUR +7.41% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./130/0.1/20.12.24
Current month-28.00%
1 month-29.87%
Date Price Change
05/24/05 0.56 +3.70%
04/24/04 0.54 -6.90%
03/24/03 0.58 -15.94%
02/24/02 0.69 -2.82%
01/24/01 0.71 -5.33%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 01:44 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB16ZV
ISINDE000MB16ZV7
Date issued 05/12/2022
Strike 130 $
Maturity 20/12/2024 (168 Days)
Parity 10 : 1
Emission price 1.02
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.17
Lowest since issue 0.126
Spread 0.02
Spread %3.39%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
125.8 USD
Average target price
142.7 USD
Spread / Average Target
+13.37%
Consensus